Show simple item record

dc.creatorMukiibi, J.M.
dc.creatorPaul, B.
dc.creatorNyirenda, C.M.
dc.creatorAdewuyi, J.O.
dc.creatorGwanzura, C.
dc.creatorMzulu, E.L.B.
dc.creatorMbvundula, E.M.
dc.creatorMagombo, E.D.
dc.date.accessioned2014-11-10T14:51:46Z
dc.date.accessioned2015-12-08T10:53:45Z
dc.date.available2014-11-10T14:51:46Z
dc.date.available2015-12-08T10:53:45Z
dc.date.created2014-11-10T14:51:46Z
dc.date.issued2004-11
dc.identifierMukiibi, J M [et al.] (2004) Chronic lymphocytic leukaemia (CLL) in Central Africans, CAJM vol. 50, no. 11. Harare, Avondale: CAJM.
dc.identifier0008-9176
dc.identifierhttp://opendocs.ids.ac.uk/opendocs/handle/123456789/5029
dc.identifier.urihttp://hdl.handle.net/10646/1773
dc.description.abstractChronic lymphocytic leukaemia (CLL) is a haematological malignancy characterized by monoclonal proliferation and accumulation of mature looking small lymphocytes particularly in the marrow, blood, lymph nodes and spleen.1-3 In 90 to 95% of cases, the cells are monoclonal B lymphocytes.3 Although in Europe and America CLL of B-cell origin is the commonest type of leukaemia, it is extremely rare before the age of 50 years, after which its incidence increases progressively with age. The male to female (M:F) ratio is 2:l.2,3 In contradistinction to these findings, CLL is rare throughout Southern, South Eastern and Eastern Asia as well as in Asians who;, migrated to North: America and Europe. This suggests genetic determinants as they usually suffer from the CLL of T-cell origin:
dc.languageen
dc.publisherCentral African Journal of Medicine (CAJM), University of Zimbabwe
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/
dc.rightsUniversity of Zimbabwe
dc.subjectHealth
dc.titleChronic lymphocytic leukaemia (CLL) in Central Africans
dc.typeArticle


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record